FindTrial
Sign In

MRCP

PROCEDURE2 trials

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre, Associazione Italiana per lo Studio del Pancreas

Conditions

BRCA1 MutationBRCA2 MutationFAMMM - Familial Atypical Mole Malignant Melanoma SyndromeFamilial Pancreatic CancerHereditary PancreatitisLynch SyndromePeutz-Jeghers SyndromeSuspected Biliary Obstruction

Phase 3

Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary Obstruction
TerminatedNCT01424657
McGill University Health Centre/Research Institute of the McGill University Health CentreSuspected Biliary Obstruction
Start: 1997-10-31End: 2002-07-31Updated: 2011-08-29

Unknown Phase

Registry of Subjects at Risk of Pancreatic Cancer
RecruitingNCT04095195
Associazione Italiana per lo Studio del PancreasBRCA1 Mutation, BRCA2 Mutation, Familial Pancreatic Cancer +4
Start: 2019-08-20End: 2045-09-20Target: 1000Updated: 2023-01-13

Related Papers

Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer
The American Journal of Gastroenterology2023-10-0318 citations
Randomised clinical trial: MRCP-first vs. ERCP-first approach in patients with suspected biliary obstruction due to bile duct stones
Alimentary Pharmacology & Therapeutics2013-09-1129 citations